Despite these findings and strong evidence that Fhit exerts tumor suppressor activity [17], [18], it has been argued that deletions within the FHIT locus in transformed cells are passenger alterations rather than cancer-driving mutations [19]. This evidence concerns the gene FHIT and cancer.